Where can I find more information about this study?
Clinical studies have unique study numbers that are included in publications and other
information about the study. The unique study numbers associated with this study are
shown below with internet links to scientific summaries and other information.
The scientific summaries include more details about the requirements for study
enrolment, the study visit schedule, results from other endpoints, and more detailed
information about adverse events.
Organization Website Study Number
European Medicines www.clinicaltrialsregister.eu 2010-021638-72
Agency
United States National www.clinicaltrials.gov NCT01313676
Institutes of Health (NIH)
GlaxoSmithKline (GSK) www.gsk- 113782
clinicalstudyregister.com
*
For readers of this document in printed form, the websites that go with the internet
links above are
https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-021638-72
https://clinicaltrials.gov/ct2/show/NCT01313676?term=113782&rank=1
https://www.gsk-clinicalstudyregister.com/search/?search_terms=113782
Your doctor can help you understand more about this study and the results. You should
not make changes to your care based on the results of this or any single study. Keep
taking your current treatment unless instructed by your doctor.
We would like to thank the patients who contributed. The results of this study will help
answer scientific questions about treating patients with COPD.
This document was developed and approved by GSK on 18th December 2017. The
information in this summary does not include additional information available after this
date.